Last reviewed · How we verify

NCT02233634: CADOS-CMR

Impact of Breathing Maneuvers on the Oxygenation Supply of the Heart Assessed With MRI in Patients With Coronary Artery Disease

Completed NA Last updated 15 December 2017
What this trial tests

NA trial testing Oxygen in Coronary Artery Disease in 36 participants. Completed in 2 November 2017.

Timeline
1 October 2014
Primary endpoint
2 November 2017
2 November 2017

Quick facts

Lead sponsorInsel Gruppe AG, University Hospital Bern
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designfactorial
Maskingsingle
Primary purposesupportive care
Enrollment36
Start date1 October 2014
Primary completion2 November 2017
Estimated completion2 November 2017
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

Insel Gruppe AG, University Hospital Bern

Who can join

18 and older, any sex, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients with an impaired blood supply of the heart routinely receive oxygen in order to improve or preserve the oxygen supply of the heart muscle in acute cardiac care. In recent studies a new innovative MRI-technique that can detect changes in oxygen supply of the heart was able to show that the administration of oxygen or fast breathing can decrease the blood supply of the arteries supplying the heart muscle with oxygen. Thus, the administration of oxygen may paradoxically impair the oxygen supply of the heart muscle. In this study the investigators want to investigate, whether the administration of exogenous oxygen via a mask alone and in combination with fast breathing leads to a decrease in oxygen supply in regions with already impaired blood supply by a narrowing of a coronary artery of the heart.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Feasibility of cardiovascular magnetic resonance to detect oxygenation deficits in patients with multi-vessel coronary artery disease triggered by breathing maneuvers.
    Fischer K, Yamaji K, Luescher S, Ueki Y, et al · · 2018 · cited 38× · PMID 29730991 · DOI 10.1186/s12968-018-0446-y
  2. Effect of Hyperoxia on Myocardial Oxygenation and Function in Patients With Stable Multivessel Coronary Artery Disease.
    Guensch DP, Fischer K, Yamaji K, Luescher S, et al · · 2020 · cited 26× · PMID 32089047 · DOI 10.1161/jaha.119.014739
  3. Hyperventilation-induced heart rate response as a potential marker for cardiovascular disease.
    Hawkins SM, Guensch DP, Friedrich MG, Vinco G, et al · · 2019 · cited 13× · PMID 31784617 · DOI 10.1038/s41598-019-54375-9

Verify or expand the search:

Other trials of Oxygen

Trials testing the same drug.

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

Other Insel Gruppe AG, University Hospital Bern trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02233634.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing